Press Room

News / Nov 29, 2021

Hovione distinguished with the Order of Engineers trophy

Mrs. Diane Villax represented Hovione at the Gala of the Order of Engineers

Diane Villax receives Order of Engineers trophy | Hovione

In the picture: Herman José, presenter of the ceremony, Diane Villax, founder chairman of Hovione, António Gonçalves da Silva, President of the College of Chemical and Biological Engineering.

 
 

The Order of Engineers (OE) in Portugal celebrated its 85th anniversary and to mark the occasion held a Gala on the 27th of November. During the ceremony, OE trophies were awarded to distinguish the best projects, works, personalities or institutions of National Engineering.

Hovione was awarded for its work in the field of pharmaceutical chemistry over more than 60 years.

The award was received by Mrs. Diane Villax on behalf of Hovione. In her acceptance speech, Mrs. Diane Villax referred to Hovione's role in research and development, highlighting the important contribution given by the Team members and the PhD’s and Master programs in progress within the company.

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025